NCT07427212

Brief Summary

Chronic coccydynia is a condition characterized by persistent pain in the coccyx region that significantly affects daily activities and quality of life. When conservative treatments fail, interventional pain procedures such as radiofrequency ablation may be considered. This single-center, prospective, randomized study compared two radiofrequency ablation techniques used in the treatment of chronic coccydynia: fluoroscopy-guided ganglion impar radiofrequency ablation and ultrasound-guided coccygeal nerve radiofrequency ablation. Adult patients with chronic coccydynia who did not respond to medical treatment were randomly assigned to receive one of these two interventions. Pain intensity and functional disability were evaluated using standardized assessment tools before the procedure and during follow-up visits at 3 weeks and 3 months after treatment. The primary objective was to compare pain relief between the two techniques at 3 months. Secondary objectives included evaluation of functional improvement and procedure-related complications. The results of this study provide comparative information on the effectiveness and safety of these two commonly used radiofrequency techniques and may help guide clinicians in selecting appropriate interventional treatments for patients with chronic coccydynia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

February 16, 2026

Last Update Submit

February 16, 2026

Conditions

Keywords

Chronic coccydynia Ganglion impar Coccygeal nerve

Outcome Measures

Primary Outcomes (1)

  • Pain reduction at 3 months

    Pain intensity was assessed using the Numeric Rating Scale (NRS). The primary outcome was defined as the proportion of patients achieving at least a 50% reduction in NRS score at 3 months compared with baseline.

    3 months

Secondary Outcomes (3)

  • Functional improvement at 3 months

    3 months

  • Change in pain intensity over time

    Baseline, 3 weeks, and 3 months

  • Procedure-related complications

    Up to 3 months

Study Arms (2)

Ganglion Impar Radiofrequency Ablation

EXPERIMENTAL

Participants underwent fluoroscopy-guided ganglion impar thermal radiofrequency ablation.

Procedure: Ganglion impar radiofrequency ablation

Coccygeal Nerve Radiofrequency Ablation

EXPERIMENTAL

Thermal radiofrequency ablation of the coccygeal nerve performed under ultrasound guidance using standard interventional pain management techniques.

Procedure: Coccygeal nerve radiofrequency ablation

Interventions

Thermal radiofrequency ablation of the ganglion impar performed under fluoroscopic guidance using standard interventional pain management techniques.

Ganglion Impar Radiofrequency Ablation

Thermal radiofrequency ablation of the coccygeal nerve performed under ultrasound guidance using standard interventional pain management techniques.

Coccygeal Nerve Radiofrequency Ablation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 75 years Diagnosis of chronic coccydynia lasting longer than 3 months Numeric Rating Scale (NRS) score ≥ 4 at baseline Inadequate response to conservative medical treatment Ability to understand the study procedures and provide written informed consent

You may not qualify if:

  • Acute coccygeal fracture or recent trauma Local or systemic infection Known malignancy involving the pelvic or sacrococcygeal region Coagulation disorders or ongoing anticoagulant therapy that cannot be safely discontinued Known allergy to local anesthetics or materials used in the procedure Severe psychiatric disorders or cognitive impairment interfering with study participation Pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Of Health Sciences, Gulhane School Of Medicine, Department Of Algology,

Ankara, Etlik, 06010, Turkey (Türkiye)

Location

Related Publications (5)

  • Genc Perdecioglu GR, Yildiz G. Coccygeal Nerve Blockade vs. Impar Ganglion Blockade in Coccydynia: A Randomised Clinical Trial. Cureus. 2024;16(9):e69118.

    BACKGROUND
  • Can E, Yildiz G, Akkaya OT, et al. Ultrasound-Guided Coccygeal Nerve Radiofrequency Ablation and Steroid Injection: Combination Therapy for Coccydynia. J Ultrasound Med. 2024;43(1):57-64.

    BACKGROUND
  • Choudhary R, et al. Improvement in pain following ganglion impar blocks and radiofrequency ablation in coccygodynia patients: a systematic review. Rev Bras Ortop (Sao Paulo). 2021;56(5):558-566.

    BACKGROUND
  • Elkhashab Y, Ng A. A review of current treatment options for coccygodynia. Curr Pain Headache Rep. 2018;22(4):28.

    BACKGROUND
  • Patijn J, Janssen M, Hayek S, Mekhail N, Van Zundert J. Coccygodynia. Pain Pract. 2010;10(6):554-559.

    RESULT

Study Officials

  • ALP E Çelenlioğlu, MD

    Saglik Bilimleri Universitesi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 23, 2026

Study Start

November 11, 2024

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

February 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in the published article.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
3 months after publication
Access Criteria
Access to de-identified individual participant data and supporting documents, including the study protocol and statistical analysis plan, will be granted to qualified researchers upon reasonable request. Requests will be reviewed by the study investigators and must include a methodologically sound proposal. Data sharing will be conducted in accordance with institutional policies and applicable data protection regulations.

Locations